The malignant clone in Waldenstrom's macroglobulinemia
Authors:
- Brian J. TaylorBTBrian J. Taylor
- Michael J. MantMMMichael J. Mant
- Steven P. TreonSTSteven P. Treon
- Andrew R. BelchABAndrew R. Belch
- Linda M. PilarskiLPLinda M. Pilarski
- 30 April 2003
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (2) , 132-135
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptorBlood, 2001
- Splenic Marginal Zone Lymphoma With or Without Plasmacytic DifferentiationAmerican Journal of Surgical Pathology, 2000
- Waldenström's macroglobulinaemia: Laboratory diagnosis and treatmentHematological Oncology, 2000
- WALDENSTRÖM'S MACROGLOBULINEMIAHematology/Oncology Clinics of North America, 1999
- Waldenström’s macroglobulinemia is a biological syndrome which may occur during the evolution of different types of low grade B cell lymphomaLeukemia, 1999
- Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myelomaBlood, 1994
- Monoclonal Circulating B Cells in Multiple MyelomaHematology/Oncology Clinics of North America, 1992
- Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemiaAmerican Journal of Hematology, 1991
- Transition in CD45 isoform expression during differentiation of normal and abnormal B cellsInternational Immunology, 1989
- Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significanceAmerican Journal of Hematology, 1989